DarioHealth Corp.
DRIO
$0.80
-$0.02-2.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.44% | 18.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.44% | 18.67% | |||
| Cost of Revenue | -4.00% | -2.82% | |||
| Gross Profit | 5.15% | 30.88% | |||
| SG&A Expenses | -5.75% | -13.81% | |||
| Depreciation & Amortization | -4.17% | 9.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.68% | -13.33% | |||
| Operating Income | 9.07% | 25.70% | |||
| Income Before Tax | 23.22% | 9.31% | |||
| Income Tax Expenses | 1,292.31% | -- | |||
| Earnings from Continuing Operations | 21.88% | 9.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.88% | 9.40% | |||
| EBIT | 9.07% | 25.70% | |||
| EBITDA | 18.81% | 28.07% | |||
| EPS Basic | 49.41% | -189.95% | |||
| Normalized Basic EPS | 63.70% | 10.63% | |||
| EPS Diluted | 50.36% | -195.51% | |||
| Normalized Diluted EPS | 63.70% | 10.63% | |||
| Average Basic Shares Outstanding | 95.16% | 1.47% | |||
| Average Diluted Shares Outstanding | 95.16% | 1.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||